Does CMV Induced Changes in NK Lymphocyte Biology Influence the Effectiveness of Antibody Therapy Used to Treat B Cell Lymphoproliferative Diseases?

Clinical trial NCT03417414 · UNKNOWN

Trial details

NCT number: NCT03417414
Sponsor: Ottawa Hospital Research Institute
Status: UNKNOWN
Study type: OBSERVATIONAL

B Cell Lymphocytic Leukemia B Cell Non-Hodgkin's Lymphoma

Start date: 2018-03-01
Primary completion: 2021-03-01
Enrollment: 160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.